Suppr超能文献

[凝血酶和因子Xa在血管平滑肌细胞中通过酪氨酸激酶依赖性上调凝集素样氧化型低密度脂蛋白受体-1]

[Tyrosine kinase dependent lectin-like oxidized LDL receptor-1 upregulation by thrombin and factor Xa in vascular smooth muscle cells].

作者信息

Su Lin, Miao Yi-de, Sun Li-xin, Sun Ning-ling

机构信息

Department of Gerontology, People's Hospital, Peking University, Beijing 100044, China.

出版信息

Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Mar;34(3):262-6.

Abstract

OBJECTIVE

Thrombin and factor Xa are key players in the process of arterial thrombi formation and lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) is a cell surface endocytosis receptor for atherogenic oxidized LDL (ox-LDL). Here we investigate whether thrombin and factor Xa can induce LOX-1 protein expressions in cell-associated forms and soluble forms in cultured bovine aortic smooth muscle cells (BSMCs).

METHODS

BSMCs were treated with thrombin or factor Xa in the presence or absence of AG1478, an epidermal growth factor (EGF) receptor-associated tyrosine kinase inhibitor. Total cell lysates and concentrated culture medium were then analyzed by Western blot using a mouse anti-LOX-1 monoclonal antibody.

RESULTS

LOX-1 protein levels in cell lysates and culture medium were significantly increased by thrombin and factor Xa in a concentration- and time-dependent manner. Upregulation of LOX-1 protein expressions in cell lysates and concentrated culture medium was observed at concentrations above 2.0 and 3.0 U/ml of thrombin and 50 and 100 nmol/L of factor Xa, respectively. Increased LOX-1 protein expressions in cell lysates and cell culture medium were detectable as early as 4 h and peaked at 12 h after treatment with thrombin or factor Xa. LOX-1 expression induced by thrombin and factor Xa could be blocked by pretreatment with AG1478.

CONCLUSIONS

Thrombin and factor Xa can act as LOX-1 inducers via tyrosine kinase activation.

摘要

目的

凝血酶和Xa因子是动脉血栓形成过程中的关键因子,而凝集素样氧化低密度脂蛋白受体-1(LOX-1)是致动脉粥样硬化的氧化低密度脂蛋白(ox-LDL)的细胞表面内吞受体。在此,我们研究凝血酶和Xa因子是否能在培养的牛主动脉平滑肌细胞(BSMCs)中诱导细胞相关形式和可溶性形式的LOX-1蛋白表达。

方法

在存在或不存在表皮生长因子(EGF)受体相关酪氨酸激酶抑制剂AG1478的情况下,用凝血酶或Xa因子处理BSMCs。然后使用小鼠抗LOX-1单克隆抗体通过蛋白质印迹法分析总细胞裂解物和浓缩培养基。

结果

凝血酶和Xa因子以浓度和时间依赖性方式显著增加细胞裂解物和培养基中的LOX-1蛋白水平。分别在凝血酶浓度高于2.0和3.0 U/ml以及Xa因子浓度高于50和100 nmol/L时观察到细胞裂解物和浓缩培养基中LOX-1蛋白表达上调。在用凝血酶或Xa因子处理后,最早在4小时即可检测到细胞裂解物和细胞培养基中LOX-1蛋白表达增加,并在12小时达到峰值。凝血酶和Xa因子诱导的LOX-1表达可被AG1478预处理阻断。

结论

凝血酶和Xa因子可通过酪氨酸激酶激活作为LOX-诱导剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验